| The role of non-resolving inflammation in atherosclerosis C Kasikara, AC Doran, B Cai, I Tabas The Journal of clinical investigation 128 (7), 2713-2723, 2018 | 233 | 2018 |
| Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis B Cai, P Dongiovanni, KE Corey, X Wang, IO Shmarakov, Z Zheng, ... Cell metabolism 31 (2), 406-421. e7, 2020 | 197 | 2020 |
| Efferocytosis induces macrophage proliferation to help resolve tissue injury BD Gerlach, PB Ampomah, A Yurdagul, C Liu, MC Lauring, X Wang, ... Cell metabolism 33 (12), 2445-2463. e8, 2021 | 151 | 2021 |
| MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity B Cai, C Kasikara, AC Doran, R Ramakrishnan, RB Birge, I Tabas Science signaling 11 (549), eaar3721, 2018 | 134 | 2018 |
| Phosphatidylserine sensing by TAM receptors regulates AKT-dependent chemoresistance and PD-L1 expression C Kasikara, S Kumar, S Kimani, WI Tsou, K Geng, V Davra, G Sriram, ... Molecular Cancer Research 15 (6), 753-764, 2017 | 118 | 2017 |
| Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti–PD-1 mAb efficacy in a murine model of triple-negative breast cancer C Kasikara, V Davra, D Calianese, K Geng, TE Spires, M Quigley, ... Cancer research 79 (10), 2669-2683, 2019 | 89 | 2019 |
| Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity SG Kimani, K Geng, C Kasikara, S Kumar, G Sriram, Y Wu, RB Birge Frontiers in immunology 5, 566, 2014 | 77 | 2014 |
| Requirement of gamma-carboxyglutamic acid modification and phosphatidylserine binding for the activation of Tyro3, Axl, and Mertk receptors by growth arrest-specific 6 K Geng, S Kumar, SG Kimani, V Kholodovych, C Kasikara, K Mizuno, ... Frontiers in immunology 8, 1521, 2017 | 75 | 2017 |
| Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity V Davra, S Kumar, K Geng, D Calianese, D Mehta, V Gadiyar, C Kasikara, ... Cancer research 81 (3), 698-712, 2021 | 57 | 2021 |
| Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis C Kasikara, M Schilperoort, B Gerlach, C Xue, X Wang, Z Zheng, ... The Journal of Clinical Investigation 131 (8), 2021 | 38 | 2021 |
| Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase SG Kimani, S Kumar, V Davra, YJ Chang, C Kasikara, K Geng, WI Tsou, ... Cell communication and signaling 14, 1-15, 2016 | 31 | 2016 |
| Cyclophilin A inhibitor debio-025 targets Crk, reduces metastasis, and induces tumor immunogenicity in breast cancer V Davra, T Saleh, K Geng, S Kimani, D Mehta, C Kasikara, B Smith, ... Molecular cancer research 18 (8), 1189-1201, 2020 | 13 | 2020 |
| Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk G Sriram, W Jankowski, C Kasikara, C Reichman, T Saleh, KQ Nguyen, ... Oncogene 34 (32), 4260-4269, 2015 | 11 | 2015 |
| TAM receptors and their ligand-mediated activation: role in atherosclerosis B Cai, C Kasikara International review of cell and molecular biology 357, 21-33, 2020 | 9 | 2020 |
| Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis L Ozcan, C Kasikara, A Yurdagul Jr, G Kuriakose, B Hubbard, ... Plos one 16 (5), e0246600, 2021 | 4 | 2021 |
| Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28–Stimulated T Cell IFN-γ and TNF-α Production D Calianese, T Kreiss, C Kasikara, V Davra, KC Lahey, V Gadiyar, ... The Journal of Immunology 207 (2), 436-448, 2021 | 2 | 2021 |
| Differential Phosphatidylserine sensing by TAM receptors regulates AKT dependent chemoresistance and PD‐L1 expression in epithelial cells C Kasikara, S Kumar, R Birge The FASEB Journal 31, 775.10-775.10, 2017 | | 2017 |
| Phosphatidylserine Sensing by Tyro3, Axl, and Mer (TAM) Receptors Regulate Programmed Death-ligand 1 (PD-L1) and Immune Responses in Breast Cancer C Kasikara Rutgers University, School of Graduate Studies, 2017 | | 2017 |
| Abstract B119: Characterization of a phosphatidylserine, TAM receptor (Tyro3, Axl, Mertk), PDL1 axis in breast cancer C Kasikara, S Kumar, K Geng, V Davre, C Empig, B Freimark, M Gray, ... Cancer Immunology Research 4 (11_Supplement), B119-B119, 2016 | | 2016 |
| BMS-777607 C Kasikara, V Davra, D Calianese, K Geng, TE Spires, M Quigley, ... | | |
